Phillip A. Sharp Innovation in Collaboration Award: Checkpoint Inhibition in Children with Ultra-Mutated Cancer Due to Biallelic Mismatch Repair Deficiency (bMMRD) - Stand Up To Cancer

Blog

Posted October 10, 2019

Phillip A. Sharp Innovation in Collaboration Award: Checkpoint Inhibition in Children with Ultra-Mutated Cancer Due to Biallelic Mismatch Repair Deficiency (bMMRD)

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.